REGULUS THERAPEUTICS INC's ticker is RGLSXXXX and the CUSIP is 75915K101.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2017 | $39,000 | -22.0% | 23,857 | +6.9% | 0.00% | – |
Q4 2016 | $50,000 | -99.9% | 22,307 | -0.3% | 0.00% | – |
Q3 2016 | $73,805,000 | +14.4% | 22,365 | +0.2% | 0.00% | – |
Q2 2016 | $64,537,000 | -44.4% | 22,331 | +33.1% | 0.00% | – |
Q1 2016 | $116,000,000 | -20.5% | 16,778 | 0.0% | 0.00% | -100.0% |
Q4 2015 | $146,000,000 | +133845.0% | 16,778 | +1.1% | 0.00% | – |
Q3 2015 | $109,000 | -99.9% | 16,596 | +0.1% | 0.00% | -100.0% |
Q2 2015 | $181,684,000 | +24.0% | 16,577 | +91.6% | 0.00% | 0.0% |
Q1 2015 | $146,565,000 | +5.6% | 8,652 | 0.0% | 0.00% | 0.0% |
Q4 2014 | $138,778,000 | +126.5% | 8,652 | -3.5% | 0.00% | – |
Q3 2014 | $61,265,000 | -15.1% | 8,970 | -0.1% | 0.00% | – |
Q2 2014 | $72,167,000 | -1.2% | 8,976 | +10.9% | 0.00% | – |
Q1 2014 | $73,008,000 | +45.8% | 8,094 | +19.4% | 0.00% | – |
Q4 2013 | $50,082,000 | -11.4% | 6,777 | +13.1% | 0.00% | – |
Q3 2013 | $56,495,000 | -35.4% | 5,991 | -32.8% | 0.00% | -100.0% |
Q2 2013 | $87,495,000 | – | 8,919 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
RA Capital Management | 4,039,823 | $26,420,000 | 3.79% |
Foresite Capital Management II, LLC | 1,750,269 | $11,447,000 | 3.48% |
ARGONAUT CAPITAL MANAGEMENT CORP | 75,000 | $491,000 | 1.65% |
Abingworth LLP | 327,350 | $2,138,000 | 1.25% |
Trellus Management Company, LLC | 100,000 | $654,000 | 0.96% |
Cormorant Asset Management, LP | 896,522 | $5,863,000 | 0.94% |
DAFNA Capital Management LLC | 90,000 | $589,000 | 0.58% |
ORACLE INVESTMENT MANAGEMENT INC | 749,064 | $4,898,000 | 0.50% |
Foresite Capital Management II, LLC | 250,000 | $1,635,000 | 0.50% |
Foresite Capital Management II, LLC | 250,000 | $1,635,000 | 0.50% |